| Date |
Research Question / Title |
Unique ID |
Research Team |
|
April 4, 2020
|
What is the evidence for early implementation of field hospitals for COVID-19?
|
EOC040203 RR
|
EOC
|
|
April 7, 2020
|
What is the prevalence of sore throat as a symptom of COVID-19?
|
EOC040201 RR
|
EOC
|
|
April 11, 2020
|
Is the IgM or IgG immune response protective?
|
LAB040803 RR
|
Laboratory
|
|
April 15, 2020
|
At what time in the disease timeline of COVID-19 do antibodies develop?
|
LAB041402 RR
|
Laboratory
|
|
April 27, 2020
|
What is the best evidence to guide the sequence or priority of re-opening each type of healthcare service and how have the closures impacted patients?
|
EOC042202 RR
|
EOC
|
|
April 30, 2020
|
How is "compassionate visit" defined and operationalized in the context of an infectious outbreak or pandemic?
|
LTC042402 RR
|
Long Term Care
|
|
May 7, 2020
|
What are best practices for engaging family care providers during a pandemic?
|
LTC042401 RR
|
Long Term Care
|
|
May 8, 2020
|
What proportion of disease transmission is due to asymptomatic, pre-symptomatic and symptomatic cases? [Update]
|
LAB040701v2 RR
|
Laboratory
|
|
May 11, 2020
|
What percentage of COVID-19 patients have hyposmia or anosmia?
|
EOC033102 RR
|
EOC
|
|
May 19, 2020
|
What are the risk factors for severity and death associated with COVID-19?
|
EPM050901 RR
|
Epidemiology & Modelling
|
|
May 19, 2020
|
What is the relationship between antibody development and viral shedding and infectiousness? [Update]
|
LAB041601v2 RR
|
Laboratory
|
|
May 22, 2020
|
In similar jurisdictions experiencing the COVID-19 pandemic, what is the proportion of patients receiving non-invasive ventilation versus those receiving intermittent mandatory ventilation?
|
EOC052102 RR
|
EOC
|
|
June 2, 2020
|
What proportion of healthcare workers are rt-PCR positive and IgM or IgG positive? [Update]
|
LAB040802v3 RR
|
Laboratory
|
|
July 27, 2020
|
What is the definition of an outbreak versus a cluster for COVID-19 in different clinical and community settings in Canada, the US, and the UK?
|
EOC071001 RR
|
EOC
|
|
July 29, 2020
|
What are the existing policies for the re-deployment or deployment of healthcare workers whose regular work has been disrupted by COVID-19 in high-resource clinical settings?
|
EOC072701 RR
|
EOC
|
|
August 29, 2020
|
Is there evidence of risks for using infrared thermometers?
|
EOC082502 RR
|
EOC
|
|
September 8, 2020
|
What are the safety risks or disinfection concerns with the use of intubation boxes?
|
EOC090202 RR
|
EOC
|
|
September 29, 2020
|
What is the evidence that runny nose or sneezing are symptoms of COVID-19?
|
EOC092401 RR
|
EOC
|
|
October 15, 2020
|
Is there increased morbidity or mortality peri-operatively for symptomatic, asymptomatic, post-COVID patients?
|
INF092801 RR
|
Infectious Disease
|
|
November 2, 2020
|
What is the risk of reinfection from COVID-19? [Update]
|
EOC032401v3 RR
|
EOC
|
